Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Jefferson Research
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Chemed Corp Comments On H2 2013 Revenue Guidance; Reaffirms FY 2013 EPS Guidance


Thursday, 18 Jul 2013 04:02pm EDT 

Chemed Corp announced that fiscal 2013 revenue growth will be constrained in the second half of 2013. For fiscal 2013, the Company reaffirms previous guidance earnings per diluted share, excluding non-cash expense for stock options, the non-cash interest expense related to the accounting for convertible debt, litigation and other items not indicative of ongoing operations, will be in the range of $5.65 to $5.80. According to I/B/E/S Estimates, analysts were expecting the Company to report EPS of $5.66 for fiscal 2013. 

Company Quote

107.71
0.71 +0.66%
17 Dec 2014